Literature DB >> 8890757

Nitric oxide in vascular remodeling.

T Nakaki1, R Kato.   

Abstract

Vascular remodeling is a series of structural changes in blood vessels. Therefore, it may be conceivable that any humoral factors and physical forces acting on the vascular wall are involved in the remodeling processes. Cells in the vascular wall respond to the humoral and physical factors and may induce extracellular matrix, cell adhesion molecules and other humoral factors. They even grow so that cellular and noncellular components deviate from the normal population. We discuss the relationship among nitric oxide (NO), pressure and growth of smooth muscles. Decreased NO may be a consequence as well as a cause of high pressure. Similarly, high pressure is a cause as well as a consequence of decreased NO. Remodeling could be a consequence of both high pressure and decreased NO. Thus, vascular remodeling is a complex dynamic state, where any causes and results are influenced by each other. Interaction of NO and pressure is one such complexity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8890757     DOI: 10.1536/ihj.37.431

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  3 in total

1.  In vivo visualization of nitric oxide and interactions among platelets, leukocytes, and endothelium following hemorrhagic shock and reperfusion.

Authors:  Mie Hiratsuka; Tomihiro Katayama; Kazuhiko Uematsu; Masaki Kiyomura; Masaharu Ito
Journal:  Inflamm Res       Date:  2009-03-05       Impact factor: 4.575

2.  Factors predicting compensatory vascular remodelling of the carotid artery affected by atherosclerosis.

Authors:  D Saito; T Oka; A Kajiyama; N Ohnishi; T Shiraki
Journal:  Heart       Date:  2002-02       Impact factor: 5.994

3.  Involvement of inflammation and adverse vascular remodelling in the blood pressure raising effect of repeatedly heated palm oil in rats.

Authors:  Chun-Yi Ng; Yusof Kamisah; Othman Faizah; Zakiah Jubri; Hj Mohd Saad Qodriyah; Kamsiah Jaarin
Journal:  Int J Vasc Med       Date:  2012-06-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.